Market Cap

$12.8B

Volume

2.0M

Cash and Equivalents

$1.2B

EBITDA

-$634.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$255.0M

Profit Margin

77.61%

52 Week High

$80.53

52 Week Low

$21.92

Dividend

N/A

Price / Book Value

318.62

Price / Earnings

-13.64

Price / Tangible Book Value

-96.51

Enterprise Value

$12.9B

Enterprise Value / EBITDA

-21.30

Operating Income

-$643.9M

Return on Equity

1372.98%

Return on Assets

-24.77

Cash and Short Term Investments

$1.2B

Debt

$1.4B

Equity

$38.8M

Revenue

$328.6M

Unlevered FCF

-$263.9M

Sector

Biotechnology

Category

N/A